Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q1 2016 · 10-Q
Revenue$0.00$0.00— vs Q1 2015 Net Income-$508.98K-$508.98KN/M vs Q1 2015 EPS Diluted$0.00$0.00— vs Q1 2015 Operating Income-$477,940N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
Free Cash Flowderived-$251,186N/M ended Mar 31, 2016 · filed May 13, 2016 · 43 d after period end